In this webinar from SCI's Fine Chemicals Group and Young Chemists' Panel, David Lathbury discusses CMC, and provides an overview of the early development process, early formulation activities and regulatory requirements associated with early development. Finally, a brief introduction to the area of potential genotoxic impurities is given.
David Lathbury is a Process Chemistry Consultant for Astute Chemical Development Consulting Ltd.
To register to attend webinars in Season Two of the Fine Chemicals Group and Young Chemists’ Panel Webinar, visit www.soci.org/e...
Негізгі бет Early CMC Studies in Drug Development | David Lathbury | SCI YCP/FCG Webinar
No video
Пікірлер